The Rapid Response project is designed to provide seed funding to catalyze novel, high-risk, high-reward translational research that accelerates the development of therapeutics or tools for neurodegenerative diseases of aging (NDAs).
- Therapeutics should address unmet needs in the prevention, treatment and/or symptomatic management of NDAs.
- Tools should address challenges in translational research to accelerate the development and/or clinical implementation of therapeutics for NDAs (e.g., biomarkers, drug delivery systems). Projects covering only the discovery/identification of a tool are considered out of scope.
- Projects should also have preliminary data to support the hypothesis and feasibility of the project.
Funding Available
- Up to $300,000 over a 18-24 month term
Key Dates
- Information Session
- 2 April 2024
- 10am PDT
- Register Here
- LOI Deadline
- 30 April 2024
- 11am PDT
- Award Announcement
- November 2024